XATRAL Side Effects

6906259-0 | Condition Aggravated, Lichenoid Keratosis, Prurigo
on Aug 02, 2010 Male patient from FRANCE , 92 years of age, was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, lichenoid keratosis, prurigo. Xatral dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), AERIUS (View Aerius Review and Aerius Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), ATARAX (View Atarax Review and Atarax Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6578151-5 | Hepatic Encephalopathy, Hepatic Failure
Patient was taking Xatral (View Usage). Patient had the following side effects: hepatic encephalopathy, hepatic failure on Feb 09, 2010 from FRANCE Additional patient health information: Male patient , 91 years of age, was diagnosed with insomnia and. Xatral dosage: . During the same period patient was treated with IMOVANE (View Imovane Review and Imovane Label ), APROVEL (View Aprovel Review and Aprovel Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6578149-7 | Thrombocytopenia
Adverse event was reported on Feb 08, 2010 by a Male patient taking Xatral (View Usage) (Dosage: ) . Location: FRANCE , 76 years of age, After Xatral was administered, patient had the following side effects: thrombocytopenia. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), IPRATROPIUM (View Ipratropium Review and Ipratropium Label ), TERBUTALINE SULFATE (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), OFTAN SCOPOLAMIN (View Oftan-scopolamin Review and Oftan-scopolamin Label ). Patient was hospitalized.

6542630-7 | Chronic Hepatitis, Cytolytic Hepatitis, Hepatic Failure, Hepatitis Acute, Jaundice Cholestatic
on Jan 06, 2010 Male patient from FRANCE , 55 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: chronic hepatitis, cytolytic hepatitis, hepatic failure, hepatitis acute, jaundice cholestatic. Xatral dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASILIX (View Lasilix Review and Lasilix Label ), DITROPAN (View Ditropan Review and Ditropan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.


6491546-3 | Fall
on Nov 30, 2009 Male patient from FRANCE , 62 years of age, weighting 220.5 lb, was diagnosed with renal cancer and was treated with Xatral (View Usage). Patient had the following side effects: fall (What is fall?). Xatral dosage: . During the same period patient was treated with AVODART (View Avodart Review and Avodart Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), COLCHICINE (View Colchicine Review and Colchicine Label ). Patient was hospitalized.

6280049-7 | Blood Pressure Decreased, Cardiac Arrest, Convulsion, Loss Of Consciousness, Pulse Absent
Patient was taking Xatral (View Usage). After Xatral was administered, patient had the following side effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), convulsion, loss of consciousness, pulse absent on Jul 16, 2009 from CANADA Additional patient health information: Male patient , 54 years of age, weighting 176.4 lb, was diagnosed with benign prostatic hyperplasia, vitamin supplementation and. Xatral dosage: . During the same period patient was treated with MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), AVODART (View Avodart Review and Avodart Label ). Patient was hospitalized.

6260599-X | Blood Pressure Decreased, Cardiac Arrest, Convulsion
Adverse event was reported on Jun 26, 2009 by a Male patient taking Xatral (View Usage) (Dosage: ) . Location: CANADA , 54 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), convulsion. During the same period patient was treated with MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), AVODART (0.5 Mg) (View Avodart Review and Avodart Label ). Patient was hospitalized.

6247765-4 | Decreased Appetite, Eructation, Hepatitis Cholestatic, Jaundice, Weight Decreased
on Jun 16, 2009 Male patient from NETHERLANDS , weighting 128.5 lb, was diagnosed with incontinence and was treated with Xatral (View Usage). Patient had the following side effects: decreased appetite, eructation, hepatitis cholestatic, jaundice (What is jaundice?), weight decreased. Xatral dosage: . Patient was hospitalized.

6215270-7 | Atrial Fibrillation
on May 25, 2009 Male patient from CANADA , 57 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Xatral dosage: .

5527030-0 | Atrial Fibrillation
Patient was taking Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?) on Nov 15, 2007 from FRANCE Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with bladder distension and. Xatral dosage: . During the same period patient was treated with PREVISCAN (Unk) (View Previscan Review and Previscan Label ), NICARDIPINE HCL (Unk) (View Nicardipine Hcl Review and Nicardipine Hcl Label ), HYPERIUM (View Hyperium Review and Hyperium Label ).

5511120-2 | Atrial Fibrillation
Adverse event was reported on Oct 29, 2007 by a Male patient taking Xatral (View Usage) (Dosage: ) . Location: FRANCE , 76 years of age, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?).

5372418-4 | Vascular Purpura
on Jun 15, 2007 Male patient from FRANCE , 73 years of age, weighting 121.3 lb, was diagnosed with benign prostatic hyperplasia, deep vein thrombosis (What is deep vein thrombosis?), prostate cancer (What is prostate cancer?) and was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: vascular purpura. Xatral dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ), ENANTONE (Unk) (View Enantone Review and Enantone Label ). Patient was hospitalized.

5306176-6 | Hyponatraemia, Orthostatic Hypotension
on Apr 12, 2007 Male patient from FRANCE , 84 years of age, was diagnosed with hypertension and was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, orthostatic hypotension. Xatral dosage: . During the same period patient was treated with IMODIUM (Unk) (View Imodium Review and Imodium Label ), CREON (Unk) (View Creon Review and Creon Label ), CORDARONE (Unk) (View Cordarone Review and Cordarone Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ), MINISINTROM (Unk) (View Minisintrom Review and Minisintrom Label ), NISIS (View Nisis Review and Nisis Label ), ALDALIX (View Aldalix Review and Aldalix Label ), AMLOR (View Amlor Review and Amlor Label ). Patient was hospitalized.

5283688-5 | Pancreatitis
Patient was taking Xatral (View Usage). Patient had the following side effects: pancreatitis on Mar 21, 2007 from GREECE Additional patient health information: Male patient , 60 years of age, . Xatral dosage: Unk. Patient was hospitalized.

5217492-0 | Hyponatraemia, Orthostatic Hypotension
Adverse event was reported on Jan 15, 2007 by a Male patient taking Xatral (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: FRANCE , 84 years of age, After Xatral was administered, patient had the following side effects: hyponatraemia, orthostatic hypotension. During the same period patient was treated with IMODIUM (Unk) (View Imodium Review and Imodium Label ), CREON (Unk) (View Creon Review and Creon Label ), CORDARONE (Unk) (View Cordarone Review and Cordarone Label ), GLIMEPIRIDE (Unk) (View Glimepiride Review and Glimepiride Label ), MINISINTROM (Unk) (View Minisintrom Review and Minisintrom Label ), NISIS (View Nisis Review and Nisis Label ), ALDALIX (View Aldalix Review and Aldalix Label ), AMLOR (View Amlor Review and Amlor Label ). Patient was hospitalized.

5162927-5 | Hepatocellular Damage, Jaundice, Transaminases Increased, Urinary Retention, Urine Colour Abnormal
on Feb 27, 2006 Male patient from FRANCE , weighting 183.0 lb, was diagnosed with prostatic adenoma, urinary retention and was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular damage, jaundice (What is jaundice?), transaminases increased, urinary retention, urine colour abnormal. Xatral dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5149838-6 | Condition Aggravated
on Oct 23, 2006 Male patient from FRANCE , weighting 187.4 lb, was diagnosed with benign prostatic hyperplasia and was treated with Xatral (View Usage). Patient had the following side effects: condition aggravated. Xatral dosage: .

5115442-9 | Asthenia, Cytolytic Hepatitis, Disseminated Intravascular Coagulation, Neutropenia, Renal Failure Acute
Patient was taking Xatral (View Usage). After Xatral was administered, patient had the following side effects: asthenia, cytolytic hepatitis, disseminated intravascular coagulation, neutropenia, renal failure acute on Aug 11, 2005 from FRANCE Additional patient health information: Male patient , 85 years of age, was diagnosed with prostate cancer metastatic and. Xatral dosage: Unk. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), ZOMETA (View Zometa Review and Zometa Label ), PROSCAR (Unk) (View Proscar Review and Proscar Label ), ZOCOR (Unk) (View Zocor Review and Zocor Label ). Patient was hospitalized.

5106387-9 | Concomitant Disease Progression, Haematocrit Decreased, Myelodysplastic Syndrome
Adverse event was reported on Mar 10, 2006 by a Male patient taking Xatral (View Usage) (Dosage: Unk, Unk) was diagnosed with benign prostatic hyperplasia, blood iron increased and. Location: GREECE , 77 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: concomitant disease progression, haematocrit decreased, myelodysplastic syndrome. During the same period patient was treated with EXJADE (Unk, No Treatment) (View Exjade Review and Exjade Label ). Patient was hospitalized.

5013515-2 | Syncope, Torsade De Pointes, Ventricular Extrasystoles
on Aug 24, 2005 Male patient from FRANCE , weighting 163.1 lb, was diagnosed with prostatic adenoma, epilepsy (What is epilepsy?), dyslipidaemia and was treated with Xatral (View Usage). Patient had the following side effects: syncope, torsade de pointes, ventricular extrasystoles. Xatral dosage: . During the same period patient was treated with THERALENE (Unk) (View Theralene Review and Theralene Label ), LODALES (View Lodales Review and Lodales Label ), RIVOTRIL (Unk) (View Rivotril Review and Rivotril Label ), DEPAKENE (Unk) (View Depakene Review and Depakene Label ). Patient was hospitalized.

5006533-1 | Hepatocellular Damage, Jaundice, Transaminases Increased, Urine Colour Abnormal
on Feb 27, 2006 Male patient from FRANCE , weighting 183.0 lb, was diagnosed with prostatic adenoma, urinary retention and was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: hepatocellular damage, jaundice (What is jaundice?), transaminases increased, urine colour abnormal. Xatral dosage: . During the same period patient was treated with LEVOTHYROX (View Levothyrox Review and Levothyrox Label ).

4994156-X | Coma, Dyspnoea, Hypotension, Miosis, Respiratory Disorder, Urinary Retention
Patient was taking Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: coma, dyspnoea, hypotension, miosis, respiratory disorder, urinary retention on Apr 25, 2006 from FRANCE Additional patient health information: Male patient , 52 years of age, . Xatral dosage: . During the same period patient was treated with ACICLOVIR MERCK (View Aciclovir Merck Review and Aciclovir Merck Label ), MOPRAL (View Mopral Review and Mopral Label ), INDOCID (2 Df) (View Indocid Review and Indocid Label ), MORPHINE CHLORHYDRATE (View Morphine Chlorhydrate Review and Morphine Chlorhydrate Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), GARDENAL (100 Mg) (View Gardenal Review and Gardenal Label ), LOVENOX (View Lovenox Review and Lovenox Label ), NOZINAN (View Nozinan Review and Nozinan Label ). Patient was hospitalized.

4975446-3 | Agranulocytosis, Septic Shock
Adverse event was reported on Apr 05, 2006 by a Male patient taking Xatral (View Usage) (Dosage: ) . Location: FRANCE , 81 years of age, weighting 154.3 lb, Patient had the following side effects: agranulocytosis, septic shock. During the same period patient was treated with PRIMPERAN TAB (30 Mg) (View Primperan Tab Review and Primperan Tab Label ), CORDARONE (View Cordarone Review and Cordarone Label ), LOVENOX (View Lovenox Review and Lovenox Label ), TRIATEC (5 Mg) (View Triatec Review and Triatec Label ), ATARAX (View Atarax Review and Atarax Label ), LYTOS (Unk) (View Lytos Review and Lytos Label ), DUPHALAC (Unk) (View Duphalac Review and Duphalac Label ), LANSOYL (Unk) (View Lansoyl Review and Lansoyl Label ). Patient was hospitalized.

4975436-0 | Photodermatosis, Swelling Face
on Apr 07, 2006 Male patient from UNITED KINGDOM , 53 years of age, weighting 191.8 lb, was diagnosed with psoriasis and was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: photodermatosis, swelling face. Xatral dosage: .

4967487-7 | Concomitant Disease Progression, Haematocrit Decreased
on Mar 10, 2006 Male patient from GREECE , 77 years of age, weighting 172.0 lb, was diagnosed with benign prostatic hyperplasia, refractory anaemia with excess blasts in transformation, blood iron increased and was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: concomitant disease progression, haematocrit decreased. Xatral dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), ICL670A (1500 Mg, Qd) (View Icl670a Review and Icl670a Label ). Patient was hospitalized.

4966492-4 | Iris Disorder
Patient was taking Xatral (View Usage). Patient had the following side effects: iris disorder on Mar 07, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 85 years of age, was diagnosed with benign prostatic hyperplasia, myocardial ischaemia, hypertension, hyperlipidaemia, chronic obstructive pulmonary disease and. Xatral dosage: . During the same period patient was treated with ASPIRIN DISP (75 Mg) (View Aspirin Disp Review and Aspirin Disp Label ), LISINOPRIL (2.5 Mg) (View Lisinopril Review and Lisinopril Label ), ATORVASTATIN CALCIUM (10 Mg) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FUROSEMIDE (20 Mg) (View Furosemide Review and Furosemide Label ), SALBUTAMOL (100 Mcg) (View Salbutamol Review and Salbutamol Label ).

4960287-3 | Concomitant Disease Progression, Haematocrit Decreased
Adverse event was reported on Mar 10, 2006 by a Male patient taking Xatral (View Usage) (Dosage: ) was diagnosed with blood iron increased and. Location: GREECE , 77 years of age, weighting 172.0 lb, After Xatral was administered, patient had the following side effects: concomitant disease progression, haematocrit decreased. During the same period patient was treated with ICL670A (1500 Mg, Qd) (View Icl670a Review and Icl670a Label ). Patient was hospitalized.

4948915-X | Concomitant Disease Progression, Haematocrit Decreased
on Mar 10, 2006 Male patient from GREECE , 77 years of age, weighting 172.0 lb, was diagnosed with blood iron increased and was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: concomitant disease progression, haematocrit decreased. Xatral dosage: . During the same period patient was treated with ICL670A (1500 Mg, Qd) (View Icl670a Review and Icl670a Label ). Patient was hospitalized.

4947137-6 | Iris Disorder
on Mar 07, 2006 Male patient from UNITED KINGDOM , 85 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Xatral (View Usage). Patient had the following side effects: iris disorder. Xatral dosage: Unk.

4944512-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Transaminases Increased
Patient was taking Xatral (View Usage). After Xatral was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, transaminases increased on Feb 27, 2006 from FRANCE Additional patient health information: Male patient , 62 years of age, . Xatral dosage: Unk. During the same period patient was treated with LEVOTHYROX (Unk) (View Levothyrox Review and Levothyrox Label ).

4937030-7 | Myoclonus
Adverse event was reported on Feb 27, 2006 by a Male patient taking Xatral (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia, urinary tract infection (What is urinary tract infection?) and. Location: ALGERIA , 60 years of age, Patient experienced the following unwanted or unexpected effects: myoclonus. During the same period patient was treated with PIPRAM (View Pipram Review and Pipram Label ).

4903700-X | Arthralgia, Osteonecrosis
on Jan 27, 2006 Male patient from FRANCE , 63 years of age, was diagnosed with lung cancer metastatic and was treated with Xatral (View Usage). Patient had the following side effects: arthralgia, osteonecrosis (What is osteonecrosis?). Xatral dosage: . During the same period patient was treated with TAXOTERE (Unk) (View Taxotere Review and Taxotere Label ), SOPHIDONE (10 Unit) (View Sophidone Review and Sophidone Label ), ZOMETA (View Zometa Review and Zometa Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ), NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

4903300-1 | Arrhythmia, Dizziness, Dysuria, Malaise, Temporal Lobe Epilepsy, Therapeutic Response Decreased
on Apr 20, 2005 Male patient from FRANCE , weighting 172.0 lb, was diagnosed with prostatic adenoma and was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), dizziness (What is dizziness?), dysuria, malaise, temporal lobe epilepsy, therapeutic response decreased. Xatral dosage: . Patient was hospitalized.

4900437-8 | Anaphylactoid Reaction, Angioneurotic Oedema, Dyspnoea, Face Oedema, Hypotension, Malaise, Pharyngeal Oedema, Pulmonary Embolism
Patient was taking Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, angioneurotic oedema, dyspnoea, face oedema, hypotension, malaise, pharyngeal oedema, pulmonary embolism (What is pulmonary embolism?) on Jan 27, 2006 from FRANCE Additional patient health information: Male patient , 56 years of age, was diagnosed with micturition disorder, micturition urgency and. Xatral dosage: .

4874323-6 | Fall, Loss Of Consciousness, Malaise, Vertigo, Vision Blurred
Adverse event was reported on Dec 28, 2005 by a Male patient taking Xatral (View Usage) (Dosage: ) was diagnosed with prostatic disorder and. Location: FRANCE , 64 years of age, weighting 92.59 lb, Patient had the following side effects: fall (What is fall?), loss of consciousness, malaise, vertigo, vision blurred. During the same period patient was treated with NORSET (View Norset Review and Norset Label ), VALIUM (View Valium Review and Valium Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), GARDENAL (View Gardenal Review and Gardenal Label ), TRIATEC (View Triatec Review and Triatec Label ). Patient was hospitalized.

4872489-5 | Arrhythmia, Dizziness, Malaise, Temporal Lobe Epilepsy
on Apr 20, 2005 Male patient from FRANCE , 67 years of age, was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), dizziness (What is dizziness?), malaise, temporal lobe epilepsy. Xatral dosage: .

4869577-6 | Fall, Hypotension, International Normalised Ratio Increased, Renal Failure
on Dec 20, 2005 Female patient from FRANCE , 91 years of age, was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hypotension, international normalised ratio increased, renal failure. Xatral dosage: . During the same period patient was treated with PREVISCAN (1/4 To 1/2 Tablet Daily) (View Previscan Review and Previscan Label ), TENORMIN (View Tenormin Review and Tenormin Label ), AMLOR (View Amlor Review and Amlor Label ), PROZAC (View Prozac Review and Prozac Label ), MOPRAL (View Mopral Review and Mopral Label ), FORLAX (Unk) (View Forlax Review and Forlax Label ), TARDYFERON (Unk) (View Tardyferon Review and Tardyferon Label ), OROCAL D3 (Unk) (View Orocal D3 Review and Orocal D3 Label ). Patient was hospitalized.

4809208-4 | Intestinal Obstruction, Muscle Haemorrhage, Vomiting
Patient was taking Xatral (View Usage). Patient had the following side effects: intestinal obstruction, muscle haemorrhage, vomiting on Oct 13, 2005 from FRANCE Additional patient health information: Male patient , child 10 years of age, . Xatral dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ATROVENT (6 Unit) (View Atrovent Review and Atrovent Label ), LOVENOX (View Lovenox Review and Lovenox Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ), OXEOL (View Oxeol Review and Oxeol Label ). Patient was hospitalized.

4796036-1 | Syncope, Torsade De Pointes
Adverse event was reported on Aug 24, 2005 by a Male patient taking Xatral (View Usage) (Dosage: ) was diagnosed with prostatic adenoma, epilepsy (What is epilepsy?), dyslipidaemia and. Location: FRANCE , weighting 163.1 lb, After Xatral was administered, patient had the following side effects: syncope, torsade de pointes. During the same period patient was treated with DEPAKENE (Unk) (View Depakene Review and Depakene Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), LODALES (View Lodales Review and Lodales Label ), THERALENE (Unk) (View Theralene Review and Theralene Label ). Patient was hospitalized.

4772730-3 | Syncope, Torsade De Pointes
on Aug 24, 2005 Male patient from FRANCE , weighting 163.1 lb, was diagnosed with prostatic adenoma and was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: syncope, torsade de pointes. Xatral dosage: . During the same period patient was treated with LODALES (View Lodales Review and Lodales Label ), THERALENE (Unk) (View Theralene Review and Theralene Label ). Patient was hospitalized.

4761638-5 | Electrocardiogram Qt Prolonged, Syncope, Torsade De Pointes
on Aug 24, 2005 Male patient from FRANCE , 65 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Xatral (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, syncope, torsade de pointes. Xatral dosage: Unk. During the same period patient was treated with DEPAKENE (Unk) (View Depakene Review and Depakene Label ), LODALES (Unk) (View Lodales Review and Lodales Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

4750570-9 | Cytolytic Hepatitis, Disseminated Intravascular Coagulation, Multi-organ Failure, Neutropenia, Renal Failure Acute
Patient was taking Xatral (View Usage). After Xatral was administered, patient had the following side effects: cytolytic hepatitis, disseminated intravascular coagulation, multi-organ failure, neutropenia, renal failure acute on Aug 11, 2005 from FRANCE Additional patient health information: Male patient , 85 years of age, was diagnosed with prostate cancer metastatic and. Xatral dosage: Unk. During the same period patient was treated with ZOCOR (Unk) (View Zocor Review and Zocor Label ), PROSCAR (Unk) (View Proscar Review and Proscar Label ), ZOMETA (View Zometa Review and Zometa Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4742606-6 | Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Jaundice, Pancytopenia
Adverse event was reported on Mar 01, 2005 by a Male patient taking Xatral (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus non-insulin-dependent and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, jaundice (What is jaundice?), pancytopenia. During the same period patient was treated with ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), DIAMICRON (Unk) (View Diamicron Review and Diamicron Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), LOVENOX (Unk) (View Lovenox Review and Lovenox Label ).

4733216-5 | Acute Respiratory Failure, Anorexia, Dysphagia, Haemoptysis, Lung Disorder, Lymphangiosis Carcinomatosa, Nausea, Paraesthesia, Staphylococcal Infection
on Jul 25, 2005 Male patient from FRANCE , 64 years of age, weighting 156.5 lb, was treated with Xatral (View Usage). Patient had the following side effects: acute respiratory failure, anorexia, dysphagia, haemoptysis, lung disorder, lymphangiosis carcinomatosa, nausea (What is nausea?), paraesthesia, staphylococcal infection (What is staphylococcal infection?). Xatral dosage: . During the same period patient was treated with CORVASAL (8 Mg) (View Corvasal Review and Corvasal Label ), VASTAREL (Unk) (View Vastarel Review and Vastarel Label ), SKENAN (80 Mg) (View Skenan Review and Skenan Label ), TARCEVA (150 Mg) (View Tarceva Review and Tarceva Label ). Patient was hospitalized.

4699348-5 | Angina Pectoris, Chest Discomfort, Pallor
on Jun 14, 2005 Male patient from , weighting 172.0 lb, was diagnosed with benign prostatic hyperplasia, diabetes mellitus and was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: angina pectoris, chest discomfort, pallor. Xatral dosage: . During the same period patient was treated with AMAREL (View Amarel Review and Amarel Label ), GLUCOPHAGE R (View Glucophage R Review and Glucophage R Label ), ANDROCUR (View Androcur Review and Androcur Label ). Patient was hospitalized.

4694583-4 | Angina Pectoris
Patient was taking Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris on Jun 08, 2005 from Additional patient health information: Male patient , 65 years of age, . Xatral dosage: . Patient was hospitalized.

4673497-X | Migraine With Aura, Vomiting
Adverse event was reported on May 13, 2005 by a Male patient taking Xatral (View Usage) (Dosage: 10 Mg) was diagnosed with benign prostatic hyperplasia, osteoporosis (What is osteoporosis?) and. Location: , 72 years of age, weighting 140.0 lb, Patient had the following side effects: migraine with aura, vomiting. During the same period patient was treated with RISEDRONATE SODIUM (35 Mg) (View Risedronate Sodium Review and Risedronate Sodium Label ).

4664665-1 | Pyrexia, Rash, Toxic Epidermal Necrolysis
on May 06, 2005 Male patient from , 85 years of age, was diagnosed with urinary retention and was treated with Xatral (View Usage). After Xatral was administered, patient had the following side effects: pyrexia, rash (What is rash?), toxic epidermal necrolysis. Xatral dosage: Unk. During the same period patient was treated with CARVEDILOL (Unk) (View Carvedilol Review and Carvedilol Label ), ISOSORBIDE DINITRATE (Unk) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), LOSEC (Unk) (View Losec Review and Losec Label ), VITAMIN B COMPLEX CAP (Unk) (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), CHLORPHENIRAMINE MALEATE (Unk) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ). Patient was hospitalized.

4660392-5 | Mycosis Fungoides
on May 03, 2005 Male patient from , 80 years of age, was treated with Xatral (View Usage). Patient experienced the following unwanted or unexpected effects: mycosis fungoides. Xatral dosage: Unk.

4649675-2 | Malaise, Temporal Lobe Epilepsy
Patient was taking Xatral (View Usage). Patient had the following side effects: malaise, temporal lobe epilepsy on Apr 20, 2005 from Additional patient health information: Male patient , 67 years of age, . Xatral dosage: .